18 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
217
TYK2 inhibitors and uses thereof

Nimbus Lakshmi
16
H3 antagonists containing phenoxypiperidine core structure

Richter Gedeon
4
Dual inhibitor compounds for use in the treatment of neurodegenerative disorders and alzheimer''s disease

Fondazione Istituto Itaiano Di Tecnologia
147
8-(piperazin-1-yl)-1,2,3,4-tetrahydro-isoquinoline derivatives

Idorsia Pharmaceuticals
98
Heterocyclic inhibitors of PTPN11

The University of Texas System
14
Method of treating COVID-19

Pfizer
3
Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs.

University of California San Francisco
13
Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-beta-lactamase.

Merck Research Laboratories
6
Splicing factor SF3b as a target of the antitumor natural product pladienolide.

Eisai
10
Rigid duplex alpha-cyclodextrin reversibly connected with disulfide bonds. Synthesis and inclusion complexes.

Institute of Organic Chemistry and Biochemistry As Cr
10
Thermodynamics of molecular recognition by cyclodextrins. 1. Calorimetric titration of inclusion complexation of naphthalenesulfonates with .alpha.-, .beta.-, and .gamma.-cyclodextrins: enthalpy-entropy compensation

Himeji Institute of Technology
92
Chiral Recognition Thermodynamics of β-Cyclodextrin: The Thermodynamic Origin of Enantioselectivity and the Enthalpy-Entropy Compensation Effect

Japan Science and Technology Agency
36
Aroylguanidine-based factor Xa inhibitors: the discovery of BMS-344577.

Bristol Myers Squibb
30
Structural analysis of ARC-type inhibitor (ARC-1034) binding to protein kinase A catalytic subunit and rational design of bisubstrate analogue inhibitors of basophilic protein kinases.

University of Tartu
19
Discovery of novel spirocyclopropyl hydroxamate and carboxylate compounds as TACE inhibitors.

Schering-Plough Research Institute
9
Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors.

Bristol Myers Squibb